EW 124.76 Edwards Lifesciences Corp $EW Hit a 52 week high

New Post Public Reply Private Reply Replies (0) Message Board
DennyT
EW 124.76 Edwards Lifesciences Corp $EW Hit a 52 week high of 124.98 Currently at 124.76 +0.16 +0.13% With a day low of 124.61 and a total volume of 20,321.

EW Edwards Lifesciences Corp Recent Headline News

Roka Bioscience (ROKA) in Focus: Stock Surges 19.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - 2 hrs 37 mins ago
Roka Bioscience, Inc. (ROKA) was a big mover last session, as the company saw its shares rise over 19% on the day.
ABMD: 32.96 (-0.03), ROKA: 3.64 (+0.06), EW: 125.05 (+0.45), ANGO: 16.99 (+0.03)

Global Prosthetic Heart Valves Industry
PR Newswire - Mon Nov 10, 5:55PM CST
This report analyzes the worldwide markets for Prosthetic Heart Valves in US$ Million by the following Product Segments: Mechanical valves, and Biological/Tissue valves. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 22 companies including many key and niche players such as -
EW: 125.05 (+0.45)

After Yesterday's Rally of 1.50% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Nov 10, 5:12PM CST
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $122.73 to a high of $124.60. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $123.68 on volume of 681,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 125.05 (+0.45)

Volcano Posts Narrower-than-Expected Q3 Loss, Guides Low - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 10:10AM CST
Despite Volcano (VOLC) provided disappointing revenue guidance for 2014 on account of expected negative foreign exchange impact, management expects accelerated profitability over the near term.
ABMD: 32.96 (-0.03), VOLC: 11.07 (+0.53), EW: 125.05 (+0.45), ANGO: 16.99 (+0.03)

Strength Seen in DexCom (DXCM): Stocks Gains 14.1% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Nov 10, 8:46AM CST
DexCom (DXCM) was a big mover last session, with shares rising over 14% on the day.
ABMD: 32.96 (-0.03), DXCM: 52.97 (-0.53), EW: 125.05 (+0.45), ANGO: 16.99 (+0.03)

Earnings Flashback: Since Reporting Quarterly Results 2 Weeks Ago Edwards Lifesciences Is Up 16.7% (EW)
Comtex SmarTrend(R) - Mon Nov 10, 8:09AM CST
Two weeks ago on October 23rd, 2014 Edwards Lifesciences (NYSE:EW) reported earnings and analysts, on average, expected earnings of $0.72 on sales of $546.0 million. Edwards Lifesciences actually reported earnings of $0.80 per share on sales of $607.4 million, beating EPS estimates by $0.08 and beating revenue estimates by $61.4 million. Shares of Edwards Lifesciences have climbed from $105.19 to $122.76, representing a gain of 16.7% since the company reported earnings 18 days ago.
EW: 125.05 (+0.45)

Edwards Lifesciences To Present At Credit Suisse 2014 Healthcare Conference
PR Newswire - Fri Nov 07, 12:59PM CST
Edwards Lifesciences Corporation (NYSE: EW), the global leader in the science of heart valves and hemodynamic monitoring, is scheduled to present at the Credit Suisse 2014 Healthcare Conference at the Arizona Biltmore in Phoenix on Tuesday, November 11, 2014.
EW: 125.05 (+0.45)

Shares of EW Up 15.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Fri Nov 07, 9:17AM CST
SmarTrend identified an Uptrend for Edwards Lifesciences (NYSE:EW) on October 23rd, 2014 at $106.16. In approximately 2 weeks, Edwards Lifesciences has returned 15.30% as of today's recent price of $122.40.
EW: 125.05 (+0.45)

Downgrade Alert for Edwards Lifesciences (EW)
Comtex SmarTrend(R) - Fri Nov 07, 6:57AM CST
Edwards Lifesciences (NYSE:EW) was downgraded from Buy to Neutral at Sterne Agee today. The stock closed yesterday at $123.57 on volume of 784,000 shares, below average daily volume of 936,000. Edwards Lifesciences share prices have moved between a 52-week high of $123.68 and a 52-week low of $60.62 and closed yesterday at 104% above that low price at $123.57 per share. Over the last five market days, the 200-day moving average (MA) has gone up 1.2% while the 50-day MA has advanced 1.8%.
EW: 125.05 (+0.45)

Insider Trading Alert - EW, SLAB And LCI Traded By Insiders
at The Street - Thu Oct 30, 10:45AM CDT
Stocks with insider trader activity include EW, SLAB and LCI
LCI: 51.59 (-0.22), SLAB: 45.47 (unch), EW: 125.05 (+0.45)

Look for Shares of Edwards Lifesciences to Potentially Pullback after Yesterday's 1.45% Rise
Comtex SmarTrend(R) - Wed Oct 29, 4:26PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $118.01 to a high of $120.12. Yesterday, the shares gained 1.5%, which took the trading range above the 3-day high of $118.84 on volume of 1.4 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 125.05 (+0.45)

Compliance Notice, Dividend Announcements, New Share Repurchase Program, and Financial Results - Research Reports on Gilead, Pfizer, AbbVie, Edwards and Lilly
PR Newswire - Wed Oct 29, 7:35AM CDT
Today, Analysts Review released its research reports regarding Gilead Sciences, Inc. (NASDAQ: GILD), Pfizer Inc. (NYSE: PFE), AbbVie Inc. (NYSE: ABBV), Edwards Lifesciences Corp. (NYSE: EW) and Eli Lilly and Co. (NYSE: LLY). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7520-100free.
GILD: 108.59 (+1.57), PFE: 30.29 (+0.09), EW: 125.05 (+0.45), LLY: 68.52 (+0.17), ABBV: 64.00 (+0.21)

IDEXX Tops Q3 Earnings and Revenues; Guidance Revised - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 12:10PM CDT
Since the news release, IDEXX's (IDXX) share price has climbed 9.8% to eventually close at $138.76 yesterday.
ATEC: 1.45 (+0.03), EW: 125.05 (+0.45), IDXX: 150.97 (+3.79), ANGO: 16.99 (+0.03)

Morning Analysis on Health Care Equipment Stocks - Zimmer Holdings, Edwards Lifesciences, Varian Medical Systems, CareFusion, and Baxter Intl.
PR Newswire - Tue Oct 28, 7:35AM CDT
Investor-Edge has initiated coverage on the following equities: Zimmer Holdings Inc. (NYSE: ZMH), Edwards Lifesciences Corporation (NYSE: EW), Varian Medical Systems Inc. (NYSE: VAR), CareFusion Corporation (NYSE: CFN), and Baxter International Inc. (NYSE: BAX). Free research on these five companies can be accessed at: http://investor-edge.com/register. On Monday, October 27, 2014, the NASDAQ Composite ended at 4,485.93, up 0.05%, the Dow Jones Industrial Average edged 0.07% higher to finish the day at 16,817.94, and the S&P 500 closed at 1,961.63, down 0.15%. The gains were broad based as six out of ten sectors ended the session in positive. The S&P 500 Health Care Sector Index ended the day at 755.35, up 0.12%, with the index also advancing 5.54% in the previous three months. Register for your complimentary reports on these five stocks at:
ZMH: 111.35 (+0.93), VAR: 87.22 (+1.90), BAX: 70.83 (+0.20), CFN: 57.52 (unch), EW: 125.05 (+0.45)

Can the Rally in Edwards Lifesciences (EW) Shares Continue? - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Oct 28, 6:48AM CDT
Can the Rally in Edwards Lifesciences (EW) Shares Continue?
EW: 125.05 (+0.45)

Critical Alerts For petroleo brasileiro, SodaStream, Edwards Lifesciences, Micron and Starbucks Released By InvestorsObserver
PR Newswire - Mon Oct 27, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for PBR, SODA, EW, MU and SBUX.
SBUX: 78.17 (+0.52), MU: 33.25 (+0.16), PBR: 10.40 (-0.22), EW: 125.05 (+0.45), SODA: 21.74 (-0.01)

Edwards Lifesciences (EW) Worth Watching: Stock Up 11% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Oct 27, 8:25AM CDT
Edwards Lifesciences (EW) was a big mover last session, with shares rising 11% on the day.
BABY: 34.28 (-0.20), PACB: 6.62 (-0.02), EW: 125.05 (+0.45), ANGO: 16.99 (+0.03)

SmarTrend Watching for Potential Pullback in Shares of Edwards Lifesciences After 11.00% Gain
Comtex SmarTrend(R) - Fri Oct 24, 3:53PM CDT
Edwards Lifesciences (NYSE:EW) traded in a range yesterday that spanned from a low of $113.22 to a high of $117.94. Yesterday, the shares gained 11.0%, which took the trading range above the 3-day high of $107.87 on volume of 2.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
EW: 125.05 (+0.45)

Stocks Hold Near Session Highs; Drugmakers Shine Again
at Investor's Business Daily - Fri Oct 24, 1:50PM CDT
Stocks looked poised to end the week on a positive note Friday. The Dow Jones industrial average added 0.6%; the S&P 500 rose 0.5% and the Nasdaq picked up 0.4%. NYSE was tracking lower than Thursday's level. Nasdaq volume was tracking close to...
AMZN: 309.64 (+4.53), SYNA: 63.00 (+0.89), EW: 125.05 (+0.45), SLXP: 98.47 (+4.60), MTX: 76.77 (-0.08), CELG: 108.37 (+0.36), GILD: 108.59 (+1.57), JAZZ: 174.36 (-0.07), ALXN: 195.80 (unch), PG: 89.56 (+0.11), CTCT: 35.33 (-0.28)

Edwards Lifesciences Hits New High On Q3 Earnings
at Investor's Business Daily - Fri Oct 24, 11:29AM CDT
Medical device maker Edwards Lifesciences (EW) jumped 11% to an all-time high in the stock market today after it beat Q3 earnings estimates late Thursday and got a barrage of price-target increases from analysts. Edwards' earnings rose 14% over the...
MDT: 69.23 (+0.52), EW: 125.05 (+0.45)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Eluvio's Game-Changer: AI Integrated Direct to Stream

Updated Category News Views 2

A groundbreaking change is thrust upon the video streaming landscape, disrupting traditional workflows. Eluvio, with its Universal & Dynamic Video Intelligence Architecture, is not just tweaking the formula; it's setting a brand-new standard. Their innovations were on full display at the IBC Show 2026 in Amsterdam, and believe me, they're redefining how we think about...

Continue Reading
Geron Faces Legal Woes: Investors Watch for Fallout

Updated Category News Views 2

Legal Storm Brewing Around Geron Corporation Ah, the familiar smell of trouble in corporate paradise, and this time it's drifting from Geron Corporation (NASDAQ: GERN). If you've got your chips on the table with these guys, you'd better pony up and listen up. Kuehn Law, PLLC is lighting a fire under Geron's board, snooping on whether their head honchos scuttled their...

Continue Reading
Spencer Spirit Completes Hot Topic Acquisition

Updated Category News Views 1

Merging Forces in Retail In the latest retail reshuffle, Spencer Spirit Holdings has wrapped up its acquisition of Hot Topic, Inc., alongside its eclectic sub-brands: BoxLunch and Her Universe. This move doubles down on Spencer Spirit's ambitions to tighten its grip on the mall-based specialty retail game. If you're an investor looking for a shake-up that could redefine...

Continue Reading
Intrigue Over Guadalupe River Property Bid

Updated Category News Views 2

Straight up, a chance like this doesn't float by every day. The Guadalupe River portfolio, with its mix of entertainment, hospitality, and commercial assets up for grabs in New Braunfels, Texas, is the talk of the investor town. If you've got deep pockets and a keen eye for opportunities, you're gonna want a piece of this pie before the September 22 bid deadline hits. The...

Continue Reading
Max Stock Expands with Strategic Logistics Center

Updated Category News Views 0

Expansion in Full Swing In a move that might get tongues wagging in the boardrooms across Israel, Max Stock Limited (TASE: MAXO) just signed a hefty lease for a logistics center in Ofakim. This isn't just a modest expansion—it's a jaw-dropper at about 45,000 square meters. We're talking about a major upgrade that'll beef up their logistical backbone as they continue...

Continue Reading
Wahl's Bold Move: The Baldscaper™ Revolution

Updated Category News Views 4

A Legacy of Grooming Innovation When Wahl, a brand that's been in the grooming game for over a century, decides to go all in on a new product, you better believe it's worth a look. Wahl's new Baldscaper™ isn't just another gadget in the grooming aisle—it's a statement. Going bald can be a bold choice, and with their latest unveil, Wahl seems to be rewarding every...

Continue Reading
Ares Management Heads to Barclays Conference Spotlight

Updated Category News Views 2

All Eyes on Ares – From the Trading Floor to Barclays Nothing like the crisp snap of traders' attention when big players like Ares Management Corporation (NYSE:ARES) are set to spill some beans at a fancy conference. Come September 16, 2026, Ares' head honcho, Michael Arougheti, will be hitting the stage at the Barclays Global Financial Services Conference. It’s the...

Continue Reading
Insilico Joins HKEX Tech 100: AI and Pharma Synergies

Updated Category News Views 1

Insilico Medicine just locked down a spot in the HKEX Tech 100 Index, and that's a pretty big deal, if you ask me. This Cambridge-based outfit is making waves with its generative AI wizardry in drug discovery. It's not just about earning a tech badge of honor here; it's about opening doors to new investors and bolstering liquidity. When changes hit on September 14, 2026,...

Continue Reading
York Space Systems Faces Class Action After IPO Issues

Updated Category News Views 2

What's Up with York Space Systems? Alright, let's dive straight into this unfolding drama. York Space Systems—fresh off their IPO in January 2026—is now neck-deep in a class action lawsuit courtesy of Robbins LLP. It's a heavy hitter for folks who put money into their stock under the assumption that it was as solid as a rock. Instead, there seems to be a soft...

Continue Reading
Tahoe Truckee Life TV Series Elevates Local Flavor

Updated Category News Views 2

Meet “Tahoe Truckee Life” Kane Schaller, the face of the Tahoe Truckee Life series, is giving folks a front-row seat to the lives and landscapes that make the Reno-Tahoe region buzz. Now, I've seen shows trying to pull this off, but this one might just spark something genuine if done right. The Real Deal on Reno-Tahoe The show airs on the REAL Shows Network—a...

Continue Reading

Top 5 Most Recently Viewed Articles

Capri Holdings Faces Securities Fraud Lawsuit Amid Merger Troubles

Updated Category News Views 516

Capri Holdings Ltd. Under Legal Scrutiny In recent news, Capri Holdings Ltd. is facing serious allegations as a securities fraud lawsuit has been filed against the company and its executives. This has raised alarms among investors, particularly those with stakes in the company amidst recent merger developments. The Merger Announcement and Background The troubles began...

Continue Reading
Currency Exchange International Prepares for Q3 Earnings Call

Updated Category News Views 130

Currency Exchange International to Release Q3 Financial Results Currency Exchange International, Corp. (TSX: CXI; OTCQX: CURN) is set to announce its financial results for the third quarter of 2025 on a notable date. The company, known for its extensive range of foreign exchange services, will disclose its performance figures after market close on September 10, 2025. This...

Continue Reading
Understanding the Gaps in Manager-Employee Engagement

Updated Category News Views 164

Research Highlights on Manager and Employee Engagement The American Management Association (AMA) has unveiled its latest findings regarding the significant disconnect between managers and employees in workplaces today. This research, based on insights gathered from over 1,300 professionals globally, presents crucial revelations about how effectively managers are perceived...

Continue Reading
Blaire McClanahan Earns Recognition as Emerging Legal Leader

Updated Category News Views 77

Blaire McClanahan Receives Prestigious 40 Under 40 Award The Law Offices of Cheryl David is thrilled to announce that attorney Blaire McClanahan has been honored in the Triad Business Journal's 2026 "40 Under 40" list. This esteemed recognition celebrates young professionals who are significantly impacting their communities through diverse industries. About the 40 Under...

Continue Reading
Unlocking ITSM Modernization: The Rise of AI and Automation

Updated Category News Views 285

Unlocking ITSM Modernization: The Rise of AI and Automation IT leaders are experiencing a significant shift in the IT landscape, rapidly adopting automation and artificial intelligence (AI) to drive IT Service Management (ITSM) modernization initiatives. With the increasing demand for IT resources, these leaders face the dual challenge of improving operational efficiency...

Continue Reading